APA

Novakovic A. M., Thorsted A., Schindler E., Jönsson S., Munafo A. & Karlsson M. O. (20191009). Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials. : Journal of clinical pharmacology.

Chicago

Novakovic A M, Thorsted A, Schindler E, Jönsson S, Munafo A and Karlsson M O. 20191009. Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials. : Journal of clinical pharmacology.

Harvard

Novakovic A. M., Thorsted A., Schindler E., Jönsson S., Munafo A. and Karlsson M. O. (20191009). Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials. : Journal of clinical pharmacology.

MLA

Novakovic A M, Thorsted A, Schindler E, Jönsson S, Munafo A and Karlsson M O. Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials. : Journal of clinical pharmacology. 20191009.